Fluocinonide NDC 43386-026

NDC codes

FDA NDC Directory

Product NDC (as listed)43386-026Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43386-0026Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43386-026-02	43386002602	1 BOTTLE in 1 CARTON (43386-026-02) / 20 mL in 1 BOTTLEMarketed from Jul 21, 2017
43386-026-06	43386002606	1 BOTTLE in 1 CARTON (43386-026-06) / 60 mL in 1 BOTTLEMarketed from Jul 21, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fluocinonide
Generic name (nonproprietary): fluocinonide
Active ingredients: Fluocinonide — .5 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Lupin Pharmaceuticals,Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206003
Marketing start: Jul 21, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 43386-026_465101b9-6374-4ce8-b64d-97e296f5c72aSPL ID 465101b9-6374-4ce8-b64d-97e296f5c72aSPL set ID 43b7621c-6628-4b54-af32-32efd0f722daRxCUI 310364UNII 2W4A77YPAN
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443386002602 followed by a unit qualifier and the quantity

Package 43386-0026-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 20, 2018.

Indications (excerpt from the label)

INDICATIONS AND USAGE Fluocinonide Topical Solution USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206003

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206003
Product	Strength	Form · route	Labeler	Product NDC
fluocinonide	Fluocinonide .5 mg/mL	SolutionTopical	Novel Laboratories, Inc.	40032-026